Work

NCIC CTG IND 103: a Phase I and pharmacokinetic (PK) study of the novel L-nucleoside analog troxacitabine (BCH-4556) given every 21 days

Year: 1999

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(99)81560-3

Authors: M. Moore, K. Belanger, J. Jolivet, S. Baker, N. Wainman, L. Seymour

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2011882990

FWCI: 0.976

Cites:

Cited by: 6

Related to: 10